読書リサーチレーダー投資フレームワーク
ログイン / 新規登録
← 読解に戻る
ニューストピック · Oura Health重大2 分で読めるDisconfirmAI 編集部

Smart Ring Maker Oura Acquires AI-Native Primary Care Startup Counsel Health for $625M After Postponing IPO

Oura acquired AI-native primary care startup Counsel Health for $625M weeks after postponing its IPO, disclosing FY2026 revenue of ~$1.75B (+92% YoY) and signaling a strategic pivot toward integrated AI healthcare services.

2026-11-11 03:23 GMT+8

US-based smart ring manufacturer Oura Health announced on November 10, 2026, that it will acquire AI-native primary care startup Counsel Health for $625 million. The deal comes just a few weeks after Oura indefinitely postponed its up to $2.2 billion IPO, citing "uncertainty in the IPO market."

Counsel Health is an AI-powered healthcare platform that combines a chat-based medical experience with access to licensed physicians. Its service was integrated into the Oura app in June, allowing users to get personalized medical advice via AI and chat with doctors when needed. The acquisition aims to expand their partnership across preventative, acute, specialty, and chronic care.

"Oura helps members understand their physiology and, with Counsel, they can take action on their health across a range of needs, from quick questions and prescriptions to lab results, chronic care, and referrals," said Oura CEO Tom Hale. According to Bloomberg, Counsel Health CEO Muthu Alagappan will join Oura as chief clinical AI officer, along with the company's 70 employees.

Financial disclosures reveal that Oura's revenue grew 153% year-over-year to $533 million for the quarter ended September 30. For fiscal year 2026, Oura generated approximately $1.75 billion in revenue, marking 92% year-over-year growth. The company reached an $11 billion valuation following a $900 million late-stage funding round in October 2025. Counsel Health had raised a $25 million Series A led by Andreessen Horowitz (a16z) and GV last year, with Pitchbook estimating total fundraising at around $36 million.

The deal is expected to close before the end of 2027. Oura stated that Counsel will continue serving existing and new enterprise partners post-acquisition, aiming to expand its AI-native care model beyond Oura's membership base.

ログイン / 新規登録
読書リサーチレーダー投資フレームワーク

ソース

  • techcrunch.comTechCrunch↗
トピック

Oura Health

芬兰健康科技公司 Oura(奥拉)宣布以6.25亿美元现金收购美国AI原生初级保健公司 Counsel Health。此举发生在 Oura 因“IPO市场不确定性”推迟其高达22亿美元的上市计划数周后,标志着这家智能戒指制造商正从单纯的数据…

4 ステップ1 件更新日 2026-11-14 03:28

経緯

  1. 2026-06-01Oura 开始在应用中集成 Counsel Health 的AI医疗服务,允许用户基于生物数据获取个性化建议并连接医师。techcrunch.com ↗
  2. 2026-09-30Oura 结束2026财年,报告显示全年营收约17.5亿美元,同比增长92%;第三季度营收5.33亿美元,同比增长153%。fiercehealthcare.com ↗
  3. 2026-10-01Oura 无限期推迟原计划最高22亿美元的IPO,理由是“IPO市场的不确定性”。techcrunch.com ↗

未解決の問題

  • 收购完成后,Counsel Health 如何平衡作为独立企业服务商(面向保险公司、雇主)与作为 Oura 专属功能之间的资源分配?
  • Oura 如何将非医疗器械属性的智能戒指数据,转化为符合美国FDA或CMS(如ACCESS Model)监管要求的临床决策依据?
  • 在推迟IPO后,Oura 是否有新的融资计划或上市时间表来支持后续的医疗扩张?
トピック全文を読む →
リサーチを続ける →